-
1
-
-
4344670729
-
A specific antagonist of the p110delta catalytic component of phosphatidylinositol 3'-kinase, IC486068, enhances radiation-induced tumor vascular destruction
-
Geng , L. , J. Tan , et al.2004) "A specific antagonist of the p110delta catalytic component of phosphatidylinositol 3'-kinase, IC486068, enhances radiation-induced tumor vascular destruction. Cancer Res 64 (14) : 4893-9
-
(2004)
Cancer Res.
, vol.64
, Issue.14
, pp. 4893-4899
-
-
Geng, L.1
Tan, J.2
-
2
-
-
0041672482
-
SU11248 maintenance therapy prevents tumor regrowth after fractionated irradiation of murine tumor models
-
Schueneman , A. J. , E. Himmelfarb , et al.2003) "SU11248 maintenance therapy prevents tumor regrowth after fractionated irradiation of murine tumor models. Cancer Res 63 (14) : 4009-16
-
(2003)
Cancer Res.
, vol.63
, Issue.14
, pp. 4009-4016
-
-
Schueneman, A.J.1
Himmelfarb, E.2
-
3
-
-
40449108294
-
Noninvasive assessment of cancer response to therapy
-
Han , Z. , A. Fu , et al.2008) "Noninvasive assessment of cancer response to therapy. Nat Med 14 (3) : 343-9
-
(2008)
Nat. Med.
, vol.14
, Issue.3
, pp. 343-389
-
-
Han, Z.1
Fu., A.2
-
4
-
-
37849044904
-
A phase i study of erlotinib in combination with gemcitabine and radiation in locally advanced, non-operable pancreatic adenocarcinoma
-
Duffy , A. , J. Kortmansky , et al.2008) "A phase I study of erlotinib in combination with gemcitabine and radiation in locally adVanced, non-operable pancreatic adenocarcinoma. Ann Oncol 19 (1) : 86-91
-
(2008)
Ann. Oncol.
, vol.19
, Issue.1
, pp. 86-91
-
-
Duffy, A.1
Kortmansky, J.2
-
5
-
-
29044433659
-
Erlotinib and chemoradiation followed by maintenance erlotinib for locally and vanced pancreatic cancer: A phase i study
-
Iannitti , D. , T. Dipetrillo , et al.2005) "Erlotinib and chemoradiation followed by maintenance erlotinib for locally adVanced pancreatic cancer: a phase I study. Am J Clin Oncol 28 (6) : 570-5
-
(2005)
Am. J. Clin. Oncol.
, vol.28
, Issue.6
, pp. 570-385
-
-
Iannitti, D.1
Dipetrillo, T.2
-
6
-
-
33745183568
-
Phase i trial of erlotinib with radiation therapy in patients with glioblastoma multiforme: Results of north central cancer treatment group protocol n0177
-
Krishnan , S. , P. D. Brown , et al.2006) "Phase I trial of erlotinib with radiation therapy in patients with glioblastoma multiforme: results of North Central Cancer Treatment Group protocol N0177. Int J Radiat Oncol Biol Phys 65 (4) : 1192-9
-
(2006)
Int. J. Radiat. Oncol. Biol. Phys.
, vol.65
, Issue.4
, pp. 1192-1199
-
-
Krishnan, S.1
Brown, P.D.2
-
7
-
-
1642576220
-
Enhanced radiation-induced cell killing andprolongation of gammaH2AX foci expression by the histone deacetylase inhibitor MS-275
-
Camphausen , K. , W. Burgan , et al.2004) "Enhanced radiation-induced cell killing andprolongation of gammaH2AX foci expression by the histone deacetylase inhibitor MS-275. Cancer Res 64 (1) : 316-21
-
(2004)
Cancer Res.
, vol.64
, Issue.1
, pp. 316-321
-
-
Camphausen, K.1
Burgan, W.2
-
8
-
-
34748877735
-
Inhibition of histone deacetylation: A strategy for tumor radiosensitization
-
Camphausen , K. and P. J. Tofilon (2007) "Inhibition of histone deacetylation: a strategy for tumor radiosensitization. J Clin Oncol 25 (26) : 4051-6
-
(2007)
J. Clin. Oncol.
, vol.25
, Issue.26
, pp. 4051-4056
-
-
Camphausen, K.1
Tofilon, P.J.2
-
9
-
-
34250805910
-
Histone deacetylase inhibitor NVP-LAQ824 sensitizes human nonsmall cell lung cancer to the cytotoxic effects of ionizing radiation
-
Cuneo , K. C. , A. Fu , et al.2007) "Histone deacetylase inhibitor NVP-LAQ824 sensitizes human nonsmall cell lung cancer to the cytotoxic effects of ionizing radiation. Anticancer Drugs 18 (7) : 793-800
-
(2007)
Anticancer Drugs
, vol.18
, Issue.7
, pp. 793-800
-
-
Cuneo, K.C.1
Fu., A.2
-
10
-
-
33845741562
-
Histone deacetylase (HDAC) inhibitor LBH589 increases duration of gamma-H2AX foci and confines HDAC4 to the cytoplasm in irradiated non-small cell lung cancer
-
Geng , L. , K. C. Cuneo , et al.2006) "Histone deacetylase (HDAC) inhibitor LBH589 increases duration of gamma-H2AX foci and confines HDAC4 to the cytoplasm in irradiated non-small cell lung cancer. Cancer Res 66 (23) : 11298-304
-
(2006)
Cancer Res.
, vol.66
, Issue.23
, pp. 11298-304
-
-
Geng, L.1
Cuneo, K.C.2
-
11
-
-
0036828101
-
MS-27- 275, an inhibitor of histone deacetylase, has marked in vitro and in vivo antitumor activity against pediatric solid tumors
-
Jaboin , J. , J. Wild , et al.2002) "MS-27- 275, an inhibitor of histone deacetylase, has marked in vitro and in vivo antitumor activity against pediatric solid tumors. Cancer Res 62 (21) : 6108-15
-
(2002)
Cancer Res.
, vol.62
, Issue.21
, pp. 6108-6115
-
-
Jaboin, J.1
Wild, J.2
-
12
-
-
34547662889
-
Antitumor activity of the histone deacetylase inhibitor MS-275 in prostate cancer models
-
Qian , D. Z. , Y. F. Wei , et al.2007) "Antitumor activity of the histone deacetylase inhibitor MS-275 in prostate cancer models. Prostate 67 (11) : 1182-93
-
(2007)
Prostate
, vol.67
, Issue.11
, pp. 1182-1193
-
-
Qian, D.Z.1
Wei, Y.F.2
-
13
-
-
0034566035
-
Adenoviral-mediated p53 transgene expression sensitizes both wild-type and null p53 prostate cancer cells in vitro to radiation
-
Colletier , P. J. , F. Ashoori , et al.2000) "Adenoviral-mediated p53 transgene expression sensitizes both wild-type and null p53 prostate cancer cells in vitro to radiation. Int J Radiat Oncol Biol Phys 48 (5) : 1507-12
-
(2000)
Int. J. Radiat. Oncol. Biol. Phys.
, vol.48
, Issue.5
, pp. 1507-1512
-
-
Colletier, P.J.1
Ashoori, F.2
-
14
-
-
28844461720
-
Tp53-gene transfer induces hypersensitivity to low doses of X-rays in glioblastoma cells: A strategy to convert a radio-resistant phenotype into a radiosensitive one
-
D'Avenia , P. , A. Porrello , et al.2006) "Tp53-gene transfer induces hypersensitivity to low doses of X-rays in glioblastoma cells: a strategy to convert a radio-resistant phenotype into a radiosensitive one. Cancer Lett 231 (1) : 102-12
-
(2006)
Cancer Lett.
, vol.231
, Issue.1
, pp. 102-112
-
-
D'Avenia, P.1
Porrello, A.2
-
15
-
-
0030969022
-
P53 mediated sensitization of squamous cell carcinoma of the head and neck to radiotherapy
-
Pirollo , K. F. , Z. Hao , et al.1997) "p53 mediated sensitization of squamous cell carcinoma of the head and neck to radiotherapy. Oncogene 14 (14) : 1735-46
-
(1997)
Oncogene
, vol.14
, Issue.14
, pp. 1735-1746
-
-
Pirollo, K.F.1
Hao, Z.2
-
16
-
-
30944466631
-
Biological activities of a recombinant adenovirus p53 (SCH 58500) administered by hepatic arterial infusion in a Phase 1 colorectal cancer trial
-
Atencio , I. A. , M. Grace , et al.2006) "Biological activities of a recombinant adenovirus p53 (SCH 58500) administered by hepatic arterial infusion in a Phase 1 colorectal cancer trial. Cancer Gene Ther 13 (2) : 169-81
-
(2006)
Cancer Gene. Ther.
, vol.13
, Issue.2
, pp. 169-181
-
-
Atencio, I.A.1
Grace, M.2
-
17
-
-
33645829571
-
Multicenter phase i study of repeated intratumoral delivery of adenoviral p53 in patients with advanced non-small-cell lung cancer
-
Fujiwara , T. , N. Tanaka , et al.2006) "Multicenter phase I study of repeated intratumoral delivery of adenoviral p53 in patients with adVanced non-small-cell lung cancer. J Clin Oncol 24 (11) : 1689-99
-
(2006)
J. Clin. Oncol.
, vol.24
, Issue.11
, pp. 1689-1699
-
-
Fujiwara, T.1
Tanaka, N.2
-
18
-
-
33744529601
-
Phase I/II adenoviral p53 gene therapy for chemoradiation resistant adVanced esophageal squamous cell carcinoma
-
Shimada , H. , H. Matsubara , et al.2006) "Phase I/II adenoviral p53 gene therapy for chemoradiation resistant adVanced esophageal squamous cell carcinoma. Cancer Sci 97 (6) : 554-61
-
(2006)
Cancer Sci.
, vol.97
, Issue.6
, pp. 554-561
-
-
Shimada, H.1
Matsubara, H.2
-
19
-
-
33646457691
-
Phase I, pharmacokinetic, and pharmacodynamic study of intravenously administered Ad5CMV-p53, an adenoviral vector containing the wild-type p53 gene, in patients with adVanced cancer
-
Tolcher , A. W. , D. Hao , et al.2006) "Phase I, pharmacokinetic, and pharmacodynamic study of intravenously administered Ad5CMV-p53, an adenoviral vector containing the wild-type p53 gene, in patients with adVanced cancer. J Clin Oncol 24 (13) : 2052-8
-
(2006)
J. Clin. Oncol.
, vol.24
, Issue.13
, pp. 2052-2058
-
-
Tolcher, A.W.1
Hao, D.2
-
20
-
-
0042566165
-
Long-term outcome of phase II trial evaluating chemotherapy, chemoradiotherapy, and surgery for locoregionally advanced esophageal cancer
-
Swisher , S. G. , J. A. Ajani , et al.2003) "Long-term outcome of phase II trial evaluating chemotherapy, chemoradiotherapy, and surgery for locoregionally adVanced esophageal cancer. Int J Radiat Oncol Biol Phys 57 (1) : 120-7
-
(2003)
Int. J. Radiat. Oncol. Biol. Phys.
, vol.57
, Issue.1
, pp. 120-387
-
-
Swisher, S.G.1
Ajani, J.A.2
-
21
-
-
7444243914
-
Nitric oxide and ionizing radiation synergistically promote apoptosis and growth inhibition of cancer by activating p53
-
Cook , T. , Z. Wang , et al.2004) "Nitric oxide and ionizing radiation synergistically promote apoptosis and growth inhibition of cancer by activating p53. Cancer Res 64 (21) : 8015-21
-
(2004)
Cancer Res.
, vol.64
, Issue.21
, pp. 8015-8021
-
-
Cook, T.1
Wang, Z.2
-
22
-
-
0742304419
-
Low-dose radiotherapy (LD-RT) and the modulation of iNOS expression in adjuVant-induced arthritis in rats
-
Hildebrandt , G. , A. Radlingmayr , et al.2003) "Low-dose radiotherapy (LD-RT) and the modulation of iNOS expression in adjuVant-induced arthritis in rats. Int J Radiat Biol 79 (12) : 993-1001
-
(2003)
Int. J. Radiat. Biol.
, vol.79
, Issue.12
, pp. 993-91001
-
-
Hildebrandt, G.1
Radlingmayr, A.2
-
23
-
-
1242338769
-
Adenoviral gene transfer of the human inducible nitric oxide synthase gene enhances the radiation response of human colorectal cancer associated with alterations in tumor vascularity
-
Wang , Z. , T. Cook , et al.2004) "Adenoviral gene transfer of the human inducible nitric oxide synthase gene enhances the radiation response of human colorectal cancer associated with alterations in tumor vascularity. Cancer Res 64 (4) : 1386-95
-
(2004)
Cancer Res.
, vol.64
, Issue.4
, pp. 1386-1395
-
-
Wang, Z.1
Cook, T.2
-
24
-
-
0030124517
-
Acyclic nucleosides as antiviral compounds
-
Freeman , S. and J. M. Gardiner (1996) "Acyclic nucleosides as antiviral compounds. Mol Biotechnol 5 (2) : 125-37
-
(1996)
Mol. Biotechnol.
, vol.5
, Issue.2
, pp. 125-137
-
-
Freeman, S.1
Gardiner, J.M.2
-
25
-
-
0346243603
-
Adenovirus/ herpes simplex-thymidine kinase/ ganciclovir complex: Preliminary results of phase i trial in patients with recurrent malignant gliomas
-
Germano , I. M. , J. Fable , et al.2003) "Adenovirus/ herpes simplex-thymidine kinase/ ganciclovir complex: preliminary results of phase I trial in patients with recurrent malignant gliomas. J Neurooncol 65 (3) : 279-89
-
(2003)
J. Neurooncol.
, vol.65
, Issue.3
, pp. 279-289
-
-
Germano, I.M.1
Fable, J.2
-
26
-
-
2442767029
-
Phase I/II study of herpes simplex virus type 1 thymidine kinase suicide
-
Study Group on Gene Therapy for Glioblastoma. Hum Gene Ther
-
Klatzmann , D. , C. A. Valery , et al.1998) "phase I/II study of herpes simplex virus type 1 thymidine kinase "suicide" gene therapy for recurrent glioblastoma. Study Group on Gene Therapy for Glioblastoma. Hum Gene Ther 9 (17) : 2595-604
-
(1998)
Gene. Therapy for Recurrent Glioblastoma
, vol.9
, Issue.17
, pp. 2595-604
-
-
Klatzmann, D.1
Valery., C.A.2
-
27
-
-
0034694011
-
A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuVant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme
-
Rainov , N. G.2000) "A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuVant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme. Hum Gene Ther 11 (17) : 2389-401
-
(2000)
Hum. Gene. Ther.
, vol.11
, Issue.17
, pp. 2389-401
-
-
Rainov, N.G.1
-
28
-
-
10744227813
-
Phase i study of replication-competent adenovirus- mediated double-suicide gene therapy in combination with conventional-dose threedimensional conformal radiation therapy for the treatment of newly diagnosed, intermediate- to high-risk prostate cancer
-
Freytag , S. O. , H. Stricker , et al.2003) "Phase I study of replication-competent adenovirus- mediated double-suicide gene therapy in combination with conventional-dose threedimensional conformal radiation therapy for the treatment of newly diagnosed, intermediate- to high-risk prostate cancer. Cancer Res 63 (21) : 7497-506
-
(2003)
Cancer Res.
, vol.63
, Issue.21
, pp. 7497-506
-
-
Freytag, S.O.1
Stricker, H.2
-
29
-
-
0035879042
-
CV706, a prostate cancer-specific adenovirus variant, in combination with radiotherapy produces synergistic antitumor efficacy without increasing toxicity
-
Chen , Y. , T. DeWeese , et al.2001) "CV706, a prostate cancer-specific adenovirus variant, in combination with radiotherapy produces synergistic antitumor efficacy without increasing toxicity. Cancer Res 61 (14) : 5453-60
-
(2001)
Cancer Res.
, vol.61
, Issue.14
, pp. 5453-5460
-
-
Chen, Y.1
Deweese, T.2
-
30
-
-
22944434253
-
Oncolytic adenovirus CG7870 in combination with radiation demonstrates synergistic enhancements of antitumor efficacy without loss of specificity
-
Dilley , J. , S. Reddy , et al.2005) "Oncolytic adenovirus CG7870 in combination with radiation demonstrates synergistic enhancements of antitumor efficacy without loss of specificity. Cancer Gene Ther 12 (8) : 715-22
-
(2005)
Cancer Gene. Ther.
, vol.12
, Issue.8
, pp. 715-722
-
-
Dilley, J.1
Reddy, S.2
-
31
-
-
0035887153
-
A phase i trial of CV706, a replication-competent, PSA selective oncolytic adenovirus, for the treatment of locally recurrent prostate cancer following radiation therapy
-
DeWeese , T. L. , H. Van der Poel , et al.2001) "A phase I trial of CV706, a replication-competent, PSA selective oncolytic adenovirus, for the treatment of locally recurrent prostate cancer following radiation therapy. Cancer Res 61 (20) : 7464-72
-
(2001)
Cancer Res.
, vol.61
, Issue.20
, pp. 7464-7472
-
-
Deweese, T.L.1
Der H.Van2
-
32
-
-
33745161873
-
A phase i trial of intravenous CG7870, a replication- selective, prostate-specific antigen-targeted oncolytic adenovirus, for the treatment of hormone-refractory, metastatic prostate cancer
-
Small , E. J. , M. A. Carducci , et al.2006) " phase I trial of intravenous CG7870, a replication- selective, prostate-specific antigen-targeted oncolytic adenovirus, for the treatment of hormone-refractory, metastatic prostate cancer. Mol Ther 14 (1) : 107-17
-
(2006)
Mol. Ther.
, vol.14
, Issue.1
, pp. 107-117
-
-
Small, E.J.1
Carducci, M.A.2
-
34
-
-
0032534024
-
X-ray-induced P-selectin localization to the lumen of tumor blood vessels
-
Hallahan , D. E. , M. J. Staba-Hogan , et al.1998) "X-ray-induced P-selectin localization to the lumen of tumor blood vessels. Cancer Res 58 (22) : 5216-20
-
(1998)
Cancer Res.
, vol.58
, Issue.22
, pp. 5216-5220
-
-
Hallahan, D.E.1
Staba-Hogan, M.J.2
-
35
-
-
0029561153
-
E-selectin gene induction by ionizing radiation is independent of cytokine induction
-
Hallahan , D. , E. T. Clark , et al.1995) "E-selectin gene induction by ionizing radiation is independent of cytokine induction. Biochem Biophys Res Commun 217 (3) : 784-95
-
(1995)
Biochem. Biophys. Res. Commun.
, vol.217
, Issue.3
, pp. 784-795
-
-
Hallahan, D.1
Clark, E.T.2
-
36
-
-
0029861338
-
Radiation-mediated gene expression in the pathogenesis of the clinical radiation response
-
Hallahan , D. E.1996) "Radiation-mediated gene expression in the pathogenesis of the clinical radiation response. Semin Radiat Oncol 6 (4) : 250-67
-
(1996)
Semin. Radiat. Oncol.
, vol.6
, Issue.4
, pp. 250-267
-
-
Hallahan, D.E.1
-
37
-
-
0033212094
-
Drug-radiation interactions in tumor blood vessels
-
Hallahan , D. E. , A. Y. Chen , et al.1999) "Drug-radiation interactions in tumor blood vessels. Oncology (Williston Park) 13 (10 Suppl 5) : 71-7
-
(1999)
Oncology (Williston Park)
, vol.13
, Issue.10 SUPPL. 5
, pp. 71-7
-
-
Hallahan, D.E.1
Chen, A.Y.2
-
38
-
-
0032535999
-
Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model
-
Arap , W. , R. Pasqualini , et al.1998) "Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science 279 (5349) : 377-80
-
(1998)
Science
, vol.279
, Issue.5349
, pp. 377-380
-
-
Arap, W.1
Pasqualini, R.2
-
39
-
-
0033597209
-
Membrane dipeptidase is the receptor for a lungtargeting peptide identified by in vivo phage display
-
Rajotte , D. and E. Ruoslahti (1999) "Membrane dipeptidase is the receptor for a lungtargeting peptide identified by in vivo phage display. J Biol Chem 274 (17) : 11593-8
-
(1999)
J. Biol. Chem.
, vol.274
, Issue.17
, pp. 11593-11598
-
-
Rajotte, D.1
Ruoslahti, E.2
-
40
-
-
0038162536
-
Integrinmediated targeting of drug delivery to irradiated tumor blood vessels
-
Hallahan , D. , L. Geng , et al.2003) "Integrinmediated targeting of drug delivery to irradiated tumor blood vessels. Cancer Cell 3 : 63-74
-
(2003)
Cancer Cell
, vol.3
, pp. 63-74
-
-
Hallahan, D.1
Geng, L.2
-
41
-
-
0029932458
-
Organ targeting in vivo using phage display peptide libraries. "
-
Pasqualini , R. and E. Ruoslahti (1996) "Organ targeting in vivo using phage display peptide libraries. " Nature 380 (6572) : 364-6
-
(1996)
Nature
, vol.380
, Issue.6572
, pp. 364-386
-
-
Pasqualini, R.1
Ruoslahti, E.2
-
42
-
-
0346982051
-
Phage display
-
Smith , G. P. and V. A. Petrenko (1997) "Phage Display. Chem Rev 97 (2) : 391-410
-
(1997)
Chem. Rev.
, vol.97
, Issue.2
, pp. 391-410
-
-
Smith, G.P.1
Petrenko, V.A.2
-
43
-
-
0033961964
-
Modifications of the fiber in adenovirus vectors increase tropism for malignant glioma models
-
Staba , M. J. , T. J. Wickham , et al.2000) "Modifications of the fiber in adenovirus vectors increase tropism for malignant glioma models. Cancer Gene Ther 7 (1) : 13-9
-
(2000)
Cancer Gene. Ther.
, vol.7
, Issue.1
, pp. 13-19
-
-
Staba, M.J.1
Wickham, T.J.2
-
44
-
-
84858378956
-
Radiation- guided P-selectin targeted antibody to lung cancer
-
in press ).
-
Hariri, G., Y. Zhang, et al.2008). "Radiation- guided P-selectin targeted antibody to lung cancer. Ann Biomed Eng (in press ).
-
(2008)
Ann. Biomed. Eng.
-
-
Hariri, G.1
Zhang, Y.2
-
45
-
-
0035866771
-
Inhibition of vascular endothelial growth factor receptor signaling leads to reversal of tumor resistance to radiotherapy
-
Geng , L. , E. Donnelly , et al.2001) "Inhibition of vascular endothelial growth factor receptor signaling leads to reversal of tumor resistance to radiotherapy. Cancer Res 61 (6) : 2413-9
-
(2001)
Cancer Res.
, vol.61
, Issue.6
, pp. 2413-2419
-
-
Geng, L.1
Donnelly, E.2
-
46
-
-
1242293097
-
Broad spectrum receptor tyrosine kinase inhibitor, SU6668, sensitizes radiation via targeting survival pathway of vascular endothelium
-
Lu , B. , L. Geng , et al.2004) "Broad spectrum receptor tyrosine kinase inhibitor, SU6668, sensitizes radiation via targeting survival pathway of vascular endothelium. Int J Radiat Oncol Biol Phys 58 (3) : 844-50
-
(2004)
Int. J. Radiat. Oncol. Biol. Phys.
, vol.58
, Issue.3
, pp. 844-850
-
-
Lu, B.1
Geng, L.2
-
47
-
-
0029803150
-
Cell adhesion molecules mediate radiationinduced leukocyte adhesion to the vascular endothelium
-
Hallahan , D. , J. Kuchibhotla , et al.1996) "Cell adhesion molecules mediate radiationinduced leukocyte adhesion to the vascular endothelium. Cancer Res 56 (22) : 5150-5
-
(1996)
Cancer Res.
, vol.56
, Issue.22
, pp. 5150-5155
-
-
Hallahan, D.1
Kuchibhotla, J.2
-
48
-
-
0035816144
-
Targeting drug delivery to radiation-induced neoantigens in tumor microvasculature
-
Hallahan , D. E. , L. Geng , et al.2001) "Targeting drug delivery to radiation-induced neoantigens in tumor microvasculature. J Control Rel 74 (1-3) : 183-91
-
(2001)
J. Control. Rel.
, vol.74
, Issue.1-3
, pp. 183-191
-
-
Hallahan, D.E.1
Geng, L.2
-
49
-
-
33644839612
-
Signaling mechanisms regulating endothelial permeability
-
Mehta , D. and A. B. Malik (2006) "Signaling mechanisms regulating endothelial permeability. Physiol Rev 86 (1) : 279-367
-
(2006)
Physiol. Rev.
, vol.86
, Issue.1
, pp. 279-367
-
-
Mehta, D.1
Malik, A.B.2
|